What is the Current Share Price of Curis Lifesciences Ltd?
- Answer Field
-
Curis Lifesciences Ltd share price is for NSE ₹ 133.95 & for BSE ₹ 0.00 as on Nov 17 2025 10:01 AM.
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
As of the latest trading session, Curis Lifesciences Ltd share price is currently at ₹ 133.95, which is down by ₹ -7.05 from its previous closing. Today, the stock has fluctuated between ₹ 133.95 and ₹ 137.00. Over the past year, Curis Lifesciences Ltd has achieved a return of [-] %. In the last month alone, the return has been [-] %. Read More...
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 30.76 | 15.08 | 1.59 | 235.72 | 30.00 / 68.00 |
| BLISS GVS PHARMA LTD | 161.90 | 15.61 | 1.62 | 1711.65 | 105.05 / 190.65 |
| CIPLA LTD | 1531.65 | 22.74 | 3.75 | 123722.28 | 1310.05 / 1672.20 |
| FERMENTA BIOTECH LIMITED | 291.85 | 7.67 | 2.19 | 858.94 | 219.00 / 449.00 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 30.76 | 25.01 | 4.28 | 235.72 | 30.00 / 68.00 |
| AMRUTAJAN HEALTH LTD | 719.05 | 36.67 | 6.07 | 2078.82 | 548.05 / 829.00 |
| ASTRAZENECA PHARMA IND LT | 9155.10 | 99.01 | 28.64 | 22887.75 | 6222.35 / 10653.05 |
| BLISS GVS PHARMA LTD | 161.90 | 21.85 | 1.61 | 1711.65 | 105.05 / 190.65 |
Choose a Plan That Suits Your Goals and Needs
-18 (-4.55%)
-6 (-0.45%)
-40 (-0.34%)
-6 (-0.18%)
-8 (-0.14%)
Curis Lifesciences Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name and style of 'M/s Loreto Pharmaceutacals', pursuant to a Deed of Partnership dated 2 June, 2010. Thereafter ' M/s Loreto Pharmaceutacals' was converted from Partnership Firm to a Private Limited Company as 'Curis Lifesciences Private Limited' and received a Certificate of Incorporation dated on March 23rd, 2016 issued by Registrar of Companies, Ahmedabad. Subsequently, Company was converted into a Public Limited Company and the name of the Company was changed from 'Curis Lifesciences Private Limited' to 'Curis Lifesciences Limited' vide certified incorporated upon the conversion dated August 9, 2024, issued by the Central Processing Centre, Manesar.
Company's business is related to manufacturing of pharmaceutical products for different markets globally as well as domestic. The business is majorly on product to product basis with different marketers. Company has commenced manufacturing facility in year 2017, hence, it has experience of more than 7 years in the current line of business of the Company. The manufacturing facility of the Company is installed with capacity to manufacture 138 Crore tables / year, 15.75 Crore Capsules / year, 1,080 Kilolitre Oral Liquid/ year, 270 Tons external preparation / year and 45 Tons sterile ophthalmic ointment / year. It deal in Pharmaceutical products like Tablets, Capsules, External Preparations, Oral Liquid, Sterile Ophthalmic Ointments etc.
The Company's past and present clientele includes renowned pharma marketers and manufactures namely Arova Pharma, Express Pharmaceuticals Private Limited, Angle Biogenics Private Limited, Centurion Healthcare Private Limited, Costcon Healthcare LLP, J.B. Chemical & Pharmaceuticals Limited, Venus international, Makers Laboratories Limited and Torikaa Pharmaceuticals Limited etc. pharmaceutical manufacturing facility are situated at Sanand GIDC-II in Ahmedabad district of Gujarat, which offers easy and convenient accessibility.
Company is planning an Initial Public Issue of upto 22,50,000 Equity Shares of face value of Rs 10 each through fresh issue.
Curis Lifesciences Ltd share price is for NSE ₹ 133.95 & for BSE ₹ 0.00 as on Nov 17 2025 10:01 AM.
The market cap of Curis Lifesciences Ltd for NSE ₹ 114.00 & for BSE ₹ 0.00 as on Nov 17 2025 10:01 AM.
The 52 Week High and Low of Curis Lifesciences Ltd for NSE is ₹ 147.90 and ₹ 138.80 and for BSE is ₹ 0.00 and ₹ 0.00.
The 1 year returns on the stock has been 0.00%.
As on Nov 17 2025 10:01 AM the price-to-earnings (PE) ratio for Curis Lifesciences Ltd share is 18.68.
As on Nov 17 2025 10:01 AM, the price-to-book (PB) ratio for Curis Lifesciences Ltd share is 54.11.
You can trade in Curis Lifesciences Ltd shares with Bajaj Broking by opening a demat account.
To buy Curis Lifesciences Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Curis Lifesciences Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found